All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Introducing
Now you can personalise
your ALL Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Nicola Gökbuget is the chair of the German Multicenter Study Group for Adult ALL (GMALL), with more than 140 participating sites in Germany. She has a position as head of the Hematology/Oncology Study Center at the Medical Clinical II and Scientific Task Force Director for Clinical Trials at the University Cancer Center (UCT). She is a founding member and board member of the German Competence Network for Acute and Chronic Leukemia and the European Leukemia Network (ELN). Nicola is also co-founder and first chair of the ALL working group of the European Hematology Association (EHA).